S
Sverre E. Kjeldsen
Researcher at University of Oslo
Publications - 771
Citations - 95426
Sverre E. Kjeldsen is an academic researcher from University of Oslo. The author has contributed to research in topics: Blood pressure & Left ventricular hypertrophy. The author has an hindex of 94, co-authored 735 publications receiving 89059 citations. Previous affiliations of Sverre E. Kjeldsen include University of Michigan & Cornell University.
Papers
More filters
Journal ArticleDOI
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.
Giuseppe Mancia,Robert Fagard,Krzysztof Narkiewicz,Josep Redán,Alberto Zanchetti,Michael Böhm,Thierry Christiaens,Renata Cifkova,Guy De Backer,Anna F. Dominiczak,Maurizio Galderisi,Diederick E. Grobbee,Tiny Jaarsma,Paulus Kirchof,Sverre E. Kjeldsen,Stéphane Laurent,Athanasios J. Manolis,Peter M. Nilsson,Luis M. Ruilope,Roland E. Schmieder,Per Anton Sirnes,Peter Sleight,Margus Viigimaa,Bernard Waeber,Faiez Zannad +24 more
TL;DR: The 2013 European Society of Hypertension/European Society of Cardiology (ESH/ESC) guidelines continue to adhere to some fundamental principles that inspired the 2003 and 2007 guidelines, namely to base recommendations on properly conducted studies identified from an ext
Journal ArticleDOI
Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial
Peter S. Sever,Björn Dahlöf,Neil R Poulter,Hans Wedel,Gareth Beevers,Mark J. Caulfield,Rory Collins,Sverre E. Kjeldsen,Arni Kristinsson,Gordon T. McInnes,Jesper Mehlsen,Markku S. Nieminen,Eoin O'Brien,Jan Östergren,Ascot Investigators +14 more
TL;DR: The reductions in major cardiovascular events with atorvastatin are large, given the short follow-up time, and may have implications for future lipid-lowering guidelines.
Journal ArticleDOI
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)
Giuseppe Mansia,Guy De Backer,Anna F. Dominiczak,Renata Cifkova,Robert Fagard,Giuseppe Germanò,Guido Grassi,Anthony M. Heagerty,Sverre E. Kjeldsen,Stéphane Laurent,Krzysztof Narkiewicz,Luis M. Ruilope,Andrzej Rynkiewicz,Roland E. Schmieder,Harry A.J. Struijker Boudier,Alberto Zanchetti +15 more
TL;DR: Authors/Task Force Members: Giuseppe Mancia, co-Chairperson (Italy), Guy De Backer, Co-Chair person (Belgium), Anna Dominiczak (UK), Renata Cifkova (Czech Republic), Robert Fagard (Belgian), Giuseppo Germano (Italy) and Guido Grassi (Italy).
Journal ArticleDOI
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.
Giuseppe Mancia,Stéphane Laurent,Enrico Agabiti-Rosei,Ettore Ambrosioni,Michel Burnier,Mark J. Caulfield,Renata Cifkova,Denis Clement,Antonio Coca,Anna F. Dominiczak,Serap Erdine,Robert Fagard,Csaba Farsang,Guido Grassi,Hermann Haller,Anthony M. Heagerty,Sverre E. Kjeldsen,Wolfgang Kiowski,Jean Michel Mallion,Athanasios J. Manolis,Krzysztof Narkiewicz,Peter M. Nilsson,Michael H. Olsen,Karl H. Rahn,Josep Redon,Jose L. Rodicio,Luis M. Ruilope,Roland E. Schmieder,Harry A.J. Struijker-Boudier,Pieter A. Van Zwieten,Margus Viigimaa,Alberto Zanchetti +31 more
TL;DR: The objective of this study was to establish a baseline for the design of a systematic literature review of this type of treatment for high blood pressure using a simple, straightforward, and scalable procedure.
Journal ArticleDOI
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study
Lennart Hansson,Thomas Hedner,P. Lund-Johansen,Sverre E. Kjeldsen,Lars H Lindholm,Jan Otto Syvertsen,Jan Lanke,Ulf de Faire,Björn Dahlöf,Bengt E. Karlberg +9 more
TL;DR: Diltiazem was as effective as treatment based on diuretics, beta-blockers, or both in preventing the combined primary endpoint of all stroke, myocardial infarction, and other cardiovascular death.